#Downgrades - Dec 04, 2024 • $ACMR: Needham Downgrades to Hold from Buy • $ALEC: BofA Securities Downgrades to Underperform from Neutral - PT $1 (from $9) • $BMY: CFRA Downgrades to Hold from Buy - PT $60 • $CDMO: Stephens Downgrades to Equal Weight from Overweight - PT $12.50 (from $12) • $DTE: KeyBanc Downgrades to Sector Weight from Overweight • $ETR: KeyBanc Downgrades to Sector Weight from Overweight • $FCNCA: KBW Downgrades to Market Perform from Outperform • $HAFC: KBW Downgrades to Market Perform from Outperform • $IPGP: Northcoast Research Downgrades to Neutral from Buy • $MSM: Stephens Downgrades to Equal Weight from Overweight - PT $85 • $MTB: JPMorgan Downgrades to Neutral from Overweight - PT $223.50 (from $215) • $NVS: HSBC Downgrades to Reduce from Hold • $PNFP: KBW Downgrades to Market Perform from Outperform • $YPF: UBS Downgrades to Neutral from Buy - PT $38 (from $30)

#Upgrades - Nov 13, 2024 • $BMY: Daiwa Securities Upgrades to Outperform from Neutral - PT $65 (from $50) • $BKU: Wells Fargo Upgrades to Overweight from Equal Weight - PT $48 (from $38) • $CCCS: Morgan Stanley Upgrades to Overweight from Equalweight - PT $15 (from $14) • $CMI: Evercore ISI Upgrades to Outperform from In Line - PT $408 (from $294) • $DSP: Canaccord Upgrades to Buy from Hold - PT $18 (from $13) • $EQR: Stifel Upgrades to Buy from Hold - PT $81.50 (from $77.75) • $ONON: BTIG Upgrades to Buy from Neutral - PT $64 • $ONON: Williams Trading Upgrades to Buy from Hold - PT $60 (from $40) • $PCAR: Evercore ISI Upgrades to Outperform from In Line - PT $129 (from $99) • $PECO: Wolfe Research Upgrades to Outperform from Peerperform • $PFE: CFRA Upgrades to Buy from Hold - PT $30 • $TKR: Evercore ISI Upgrades to Outperform from In Line - PT $91 (from $87) • $TSLA: Phillip Securities Upgrades to Reduce from Sell - PT $230 (from $135) • $TSN: CFRA Upgrades to Buy from Hold - PT $74

#Upgrades - Nov 12, 2024 • $ARGX: Wolfe Research Upgrades to Outperform from Peerperform • $ARGX: Wolfe Research Upgrades to Outperform from Peerperform - PT $697 • $BKE: UBS Upgrades to Neutral from Sell - PT $46 (from $31) • $BMY: Leerink Partners Upgrades to Outperform from Market Perform - PT $73 (from $55) • $CHRW: Citi Upgrades to Buy from Neutral - PT $125 (from $117) • $CNI: Citi Upgrades to Buy from Neutral - PT $130 (from $126) • $CRI: Citi Upgrades to Neutral from Sell - PT $50 • $IFF: Morgan Stanley Upgrades to Overweight from Equalweight - PT $110 (from $111) • $IHRT: BofA Securities Upgrades to Neutral from Underperform - PT $3 (from $1) • $S: Deutsche Bank Upgrades to Buy from Hold - PT $32 (from $25) • $SABK: Janney Upgrades to Buy from Neutral • $TWLO: Wells Fargo Upgrades to Overweight from Equal Weight - PT $120 (from $80) • $VIK: Morgan Stanley Upgrades to Overweight from Equalweight - PT $49 (from $37)

STOCKS ON THE MOVE $ONCO, up 82.4% $CNEY, up 57.8% $BMY: up 4.4% premarket, Gains as FDA approves its schizophrenia drug China ADRs extend their rally on latest stimulus push $BABA: up 0.4% premarket $JD: up 2.6% premarket $PDD, up 1.33% premarket $LI: up 0.4% premarket $SAVA: down 11.7% premarket, after SEC charges co for misleading Alzheimer's drug trial claims $COST: down 1.0% premarket, after Q4 results; brokerages hike PT $DG: down 2.5% premarket, Citi downgrades Dollar General citing tough sales recovery as Walmart takes market share $ESTA: up 27.3% premarket, on US FDA nod for Motiva breast implants $KMX: up 0.7% premarket, Brokerages raise Carmax PT on expectations of recovery in US used car market $WVE: up 2.2% premarket, JP Morgan resumes coverage with 'overweight' $IONQ: up 8.1% premarket, Gains on $54.5 mln contract with US Air Force Research Lab $BMBL: down 2.2% premarket, Down after KeyBanc downgrades to 'sector weight'